101 related articles for article (PubMed ID: 12556014)
1. Bronchodilating effects of cumulative doses of formoterol from a novel multi-dose inhaler (Airmax).
Dubois EF; Röder E; Iflé RG
Respir Med; 2003 Jan; 97(1):71-4. PubMed ID: 12556014
[TBL] [Abstract][Full Text] [Related]
2. Bronchodilating effects of cumulative doses of formoterol from a novel multi-dose inhaler (Airmax).
van der Woude HJ
Respir Med; 2003 Apr; 97(4):449; author reply 449-50. PubMed ID: 12693810
[No Abstract] [Full Text] [Related]
3. Comparable efficacy and tolerability of formoterol (Foradil) administered via a novel multi-dose dry powder inhaler (Certihaler) or the Aerolizer dry powder inhaler in patients with persistent asthma.
Dahl R; Creemers JP; Van Noord J; Sips A; Della Cioppa G; Thomson M; Andriano K; Kottakis J; Fashola T
Respiration; 2004; 71(2):126-33. PubMed ID: 15031566
[TBL] [Abstract][Full Text] [Related]
4. Comparison of bronchoprotective and bronchodilator effects of a single dose of formoterol delivered by hydrofluoroalkane and chlorofluorocarbon aerosols and dry powder in a double blind, placebo-controlled, crossover study.
Houghton CM; Langley SJ; Singh SD; Holden J; Monici Preti AP; Acerbi D; Poli G; Woodcock A
Br J Clin Pharmacol; 2004 Oct; 58(4):359-66. PubMed ID: 15373928
[TBL] [Abstract][Full Text] [Related]
5. Bronchodilating effects of salbutamol from a novel inhaler Airmax.
Middle MV; Terblanché J; Perrin VL; Hertog MG
Respir Med; 2002 Jul; 96(7):493-8. PubMed ID: 12194632
[TBL] [Abstract][Full Text] [Related]
6. Delivery of formoterol from a novel multi-dose inhaler Airmax.
Zeng XM; Jones S; O'Leary D; Phelan M; Colledge J
Respir Med; 2002 Jun; 96(6):397-403. PubMed ID: 12117038
[TBL] [Abstract][Full Text] [Related]
7. Similar bronchodilation with formoterol delivered by aerolizer or turbuhaler.
Lötvall J; Mellén A; Arvidsson P; Palmqvist M; Radielovic P; Kottakis J; Pfister P
Can Respir J; 1999; 6(5):412-6. PubMed ID: 10572207
[TBL] [Abstract][Full Text] [Related]
8. Inhaled dry-powder formoterol and salmeterol in asthmatic patients: onset of action, duration of effect and potency.
Palmqvist M; Persson G; Lazer L; Rosenborg J; Larsson P; Lötvall J
Eur Respir J; 1997 Nov; 10(11):2484-9. PubMed ID: 9426083
[TBL] [Abstract][Full Text] [Related]
9. Bronchodilation of formoterol administered with budesonide: device and formulation effects.
Miller CJ; Senn S; Mezzanotte WS
Contemp Clin Trials; 2008 Mar; 29(2):114-24. PubMed ID: 17625985
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics and tolerability of formoterol in healthy volunteers after a single high dose of Foradil dry powder inhalation via Aerolizer.
Lecaillon JB; Kaiser G; Palmisano M; Morgan J; Della Cioppa G
Eur J Clin Pharmacol; 1999 Apr; 55(2):131-8. PubMed ID: 10335908
[TBL] [Abstract][Full Text] [Related]
11. Formoterol inhaled as dry powder or via pressurized metered-dose inhaler in a cumulative dose-response study.
Ullman A; Löfdahl CG; Melander B; Svedmyr N
Allergy; 1996 Oct; 51(10):745-8. PubMed ID: 8905004
[TBL] [Abstract][Full Text] [Related]
12. Oxis (formoterol given by Turbuhaler) showed as rapid an onset of action as salbutamol given by a pMDI.
Seberová E; Andersson A
Respir Med; 2000 Jun; 94(6):607-11. PubMed ID: 10921767
[TBL] [Abstract][Full Text] [Related]
13. Clinically equivalent bronchodilatation achieved with formoterol delivered via Easyhaler and Aerolizer.
Dubakiene R; Nargela R; Sakalauskas R; Vahteristo M; Silvasti M; Lähelmä S
Respiration; 2006; 73(4):441-8. PubMed ID: 16432294
[TBL] [Abstract][Full Text] [Related]
14. Onset and duration of action of single doses of formoterol inhaled via Turbuhaler.
Ringdal N; Derom E; Wåhlin-Boll E; Pauwels R
Respir Med; 1998 Aug; 92(8):1017-21. PubMed ID: 9893769
[TBL] [Abstract][Full Text] [Related]
15. Efficacy, tolerability, and effect on asthma-related quality of life of formoterol bid via multidose dry powder inhaler and albuterol QID via metered dose inhaler in patients with persistent asthma: a multicenter, randomized, double-blind, double-dummy, placebo-controlled, parallel-group study.
Busse W; Levine B; Andriano K; Lavecchia C; Yegen U
Clin Ther; 2004 Oct; 26(10):1587-98. PubMed ID: 15598475
[TBL] [Abstract][Full Text] [Related]
16. Equivalent bronchodilation with budesonide/formoterol combination via Easyhaler and Turbuhaler in patients with asthma.
Lähelmä S; Vahteristo M; Metev H; Taseva M; Stamatova N; Bartha A; Schlezák J; Sairanen U
Respir Med; 2016 Nov; 120():31-35. PubMed ID: 27817813
[TBL] [Abstract][Full Text] [Related]
17. Decreased bronchodilating effect of salbutamol in relieving methacholine induced moderate to severe bronchoconstriction during high dose treatment with long acting beta2 agonists.
van der Woude HJ; Winter TH; Aalbers R
Thorax; 2001 Jul; 56(7):529-35. PubMed ID: 11413351
[TBL] [Abstract][Full Text] [Related]
18. Flow-dependent effect of formoterol dry-powder inhaled from the Aerolizer.
Nielsen KG; Skov M; Klug B; Ifversen M; Bisgaard H
Eur Respir J; 1997 Sep; 10(9):2105-9. PubMed ID: 9311511
[TBL] [Abstract][Full Text] [Related]
19. Formoterol (OXIS) Turbuhaler as a rescue therapy compared with salbutamol pMDI plus spacer in patients with acute severe asthma.
Boonsawat W; Charoenratanakul S; Pothirat C; Sawanyawisuth K; Seearamroongruang T; Bengtsson T; Brander R; Selroos O
Respir Med; 2003 Sep; 97(9):1067-74. PubMed ID: 14509562
[TBL] [Abstract][Full Text] [Related]
20. Formoterol Turbuhaler as reliever medication in patients with acute asthma.
Rubinfeld AR; Scicchitano R; Hunt A; Thompson PJ; Van Nooten A; Selroos O
Eur Respir J; 2006 Apr; 27(4):735-41. PubMed ID: 16455838
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
